Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

NCT07548632

RecruitingPhase 2, Phase 3

Sponsor: Oculis

Conditions: Dry Eye Disease (DED)

Interventions: Artificial Tear Run-in, licaminlimab, Vehicle of licaminlimab

Countries: United States

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Key Inclusion Criteria:

* Physician diagnosis of Dry Eye Disease in the past 6 months
* Use of over-the-counter tears
* Must agree to genotype testing

Key Exclusion Criteria:

\- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety.
Locations (14)
  • Aliso Viejo, California, United States
  • Garden Grove, California, United States
  • Glendale, California, United States
  • Murrieta, California, United States
  • Newport Beach, California, United States
  • Petaluma, California, United States
  • Colorado Springs, Colorado, United States
  • Delray Beach, Florida, United States
  • Garner, North Carolina, United States
  • Shelby, North Carolina, United States
  • Cranberry Township, Pennsylvania, United States
  • Erie, Pennsylvania, United States
  • Memphis, Tennessee, United States
  • Lynchburg, Virginia, United States